Theravance Inc. (INVA)

Last Year

23-Nov-23 -- 22-Nov-24

Time Period:

0 Net Amount

Buy:	0	--
Sell:	0	--

Company Sentiment

Biotechnology

Drugs

Insider Trading Sentiment: Strong Sell

Insider Trading Sentiment: Strong Buy

Sentiment Breakdown by Insider

0

(3)

0

(2)

0

(1)

39

0

8

+1

0

+2

0

+3

Two Year Chart

23-Nov-22 -- 22-Nov-24

Price ($)

Two Year Stock Price Chart

Sentiment

Buy & Sell Volume ($)

Two Year Insider Trading Volume Chart

Recent Insider Trades

Last Transaction		Last Three Months
SEC Filing	Transaction	Insider	Sentiment	Company	Holdings Change	Buy Amount	Sell Amount	Buy Price Range	Sell Price Range
20-Jun-24 4:57 PM View:	17-Jun-24 Grant 0	Kostas Odysseas D Director		Theravance Inc. - INVA	13% 108.7K to 122.63K	0	0	--	--	Show Txns Hide Txns

20-Jun-24 4:58 PM View:	17-Jun-24 Grant 0	Schlesinger Sarah J. Director		Theravance Inc. - INVA	13% 104.71K to 118.63K	0	0	--	--	Show Txns Hide Txns

20-Jun-24 4:55 PM View:	17-Jun-24 Grant 0	Haimovitz Jules Director		Theravance Inc. - INVA	12% 116.91K to 130.83K	0	0	--	--	Show Txns Hide Txns

20-Jun-24 4:54 PM View:	17-Jun-24 Grant 0	Dipaolo Mark Director		Theravance Inc. - INVA	13% 104.71K to 118.63K	0	0	--	--	Show Txns Hide Txns

22-Aug-24 4:05 PM View:	20-Aug-24 Payment of Exercise ($18.03K)	Zhen Marianne Chief Accounting Officer		Theravance Inc. - INVA	15% 39.68K to 45.62K	0	0	--	--	Show Txns Hide Txns

20-Jun-24 5:01 PM View:	17-Jun-24 Grant 0	Srivastava Sapna Director		Theravance Inc. - INVA	46% 30.17K to 44.1K	0	0	--	--	Show Txns Hide Txns

07-Mar-24 7:04 PM View:	05-Mar-24 Grant $179.99K	Basso Stephen Chief Financial Officer		Theravance Inc. - INVA	100% 0 to 12.1K	0	0	--	--	Show Txns Hide Txns

21-May-24 8:15 PM View:	20-May-24 Payment of Exercise ($4.32K)	Ronsheim Matthew See Remarks		Theravance Inc. - INVA	33% 30.42K to 40.51K	0	0	--	--	Show Txns Hide Txns